Advertisement

Epidemiologie des malignen Melanoms der Haut

  • Gustav Wagner
Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 11)

Zusammenfassung

Trotz seines gegenüber den Basaliomen und Spinalzellenkarzinomen sehr viel selteneren Vorkommens kommt dem malignen Melanom (MM) unter den bösartigen Hauttumoren zweifellos die höchste Priorität zu, einmal weil es die schlechteste Prognose aller Hautkrebse hat, zum andern weil es in geradezu beängstigendem Maße zunimmt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adam SA, Sheaves JK, Wright NH (1981) A case-control study of the possible association between oral contraceptives and malignant melanoma. Brit J Cancer 44:45–50PubMedGoogle Scholar
  2. 2.
    Anaise D, Steinitz R, Ben Hur N (1978) Solar radiation: a possible etiological factor in malignant melanoma in Israel. Cancer 42:299–304PubMedGoogle Scholar
  3. 3.
    Anderson DE (1971) Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer 28:721–725PubMedGoogle Scholar
  4. 4.
    Anderson DE, Smith JL, McBride CM (1967) Hereditary aspects of malignant melanoma. J Amer med Ass 200:741–746Google Scholar
  5. 5.
    Axtell LM, Asire AJ, Myers MH (Eds) (1976) Cancer Patient Survival. Report Number 5. DHEW Publ No (NIH) 77–982. U.S. Dept of Health, Educat., and Welfare, Bethesda/MDGoogle Scholar
  6. 6.
    Bain Ch, Hennekens CH, Speizer FE et al. (1982) Oral contraceptive use and malignant melanoma. J nat Cancer Inst 68:537–539PubMedGoogle Scholar
  7. 7.
    Balch ChM, Mettlin C (1985) Melanoma in the United States: A national survey of 4800 patients. In ChM Balch, GW Milton (Eds): Cutaneous Melanoma. J. B. Lippincott, Philadelphia, pp 389–395Google Scholar
  8. 8.
    Balch ChM, Milton GW (Eds) (1985) Cutaneous Melanoma. J. B. Lippincott Co, PhiladelphiaGoogle Scholar
  9. 9.
    Balch ChM, Shaw HM, Soong S-J, Milton GW (1985) Changing Trends in the Clinical and Pathologic Features of Melanoma. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma, Lippincott, Philadelphia, pp 313–319Google Scholar
  10. 10.
    Balch ChM, Soong S-J, Milton GW et al. (1983) Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 52:1748–1753PubMedGoogle Scholar
  11. 11.
    Balch ChM, Soong S-J, Shaw HM, Milton GW (1985) An Analysis of Prognostic Factors in 4000 Patients with Cutaneous Melanoma. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 321–352Google Scholar
  12. 12.
    Balda BR (1981) Epidemiologie kutaner maligner Melanome. Münch med Wschr 123:1923–1926Google Scholar
  13. 13.
    Becker N, Frentzel-Beyme R, Wagner G (1984) Krebsatlas der Bundesrepublik Deutschland — Cancer Atlas of the Federal Republic of Germany. Heidelberg, SpringerGoogle Scholar
  14. 14.
    Beral V, Evans S, Shaw H, Milton G (1982) Malignant melanoma and exposure to fluorescent lighting at work. Lancet 11:290–293Google Scholar
  15. 15.
    Beral V, Evans S, Shaw H, Milton G (1983) Cutaneous factors related to the risk of malignant melanoma. Brit J Dermat 109:165–172Google Scholar
  16. 16.
    Beral V, Evans S, Shaw H, Milton G (1984) Oral contraceptive use and malignant melanoma in Australia. Brit J Cancer 50:681–685PubMedGoogle Scholar
  17. 17.
    Beral V, Ramcharan S, Faris R (1977): Malignant melanoma and oral contraceptive use among women in California. Brit J Cancer 36:804–809PubMedGoogle Scholar
  18. 18.
    Beral V, Robinson N (1981) The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Brit J Cancer 44:886–891PubMedGoogle Scholar
  19. 19.
    Boyle P, Day NE, Magnus K (1983): Mathematical modelling of malignant melanoma trends in Norway, 1953–1978. Amer J Epidem 118:887–896Google Scholar
  20. 20.
    Brachtel R, Eckes LK (1980) Augen- und Haarpigmentierung beim malignen Melanom und anderen malignen Hauttumoren. Hautarzt 31:141–144PubMedGoogle Scholar
  21. 21.
    Braun-Falco O, Landthaler M, Ryckmanns F (1979): BK-Mole-Syndrom. Fortschr Med 97:1489–1494PubMedGoogle Scholar
  22. 22.
    Cascinelli N, Morabito A, Bufalino R et al. (1980) WHO Collaborating Centres for evaluation of methods of diagnosis and treatment of melanoma. Intern J Cancer 26:733–739Google Scholar
  23. 23.
    Clark WH, Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705–726PubMedGoogle Scholar
  24. 24.
    Clark WH, Reimer RR, Greene M et al. (1978): Origin of familial malignant melanomas from heritable malanocytic lesions. Arch Dermat 114:732–738Google Scholar
  25. 25.
    Cooke KR, Skegg DC, Fräser J (1983) Trends in malignant melanoma of skin in New Zealand. Intern J Cancer 31:715–718Google Scholar
  26. 26.
    Cooke KR, Spears GF, Skegg DC (1985) Frequency of moles in a defined population. J Epidem Commun Hlth 39:48–52Google Scholar
  27. 27.
    Crombie IK (1979) Variation of melanoma incidence with latitude in North America and Europe. Brit J Cancer 40:774–781PubMedGoogle Scholar
  28. 28.
    D’Arcy C, Holman J, Armstrong BK (1984) Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma. J nat Cancer Inst 72:257–266Google Scholar
  29. 29.
    Davis NC (1981) Queensland Melanoma-Projekt. Ein Modell zur Früherkennung. In: Weidner F, Tonak J (Hrsg) Das maligne Melanoma der Haut. Perimed, Erlangen, 51–56Google Scholar
  30. 30.
    Day CL, Mihm MC, Jr, Lew RA et al. (1982) Cutaneous malignant melanoma. Prognostic guidelines for physicians and patients. CA (N.Y.) 32:113–122Google Scholar
  31. 31.
    Drzewiecki KT, Andersen PK (1982) Survival with malignant melanoma. A regression analysis of prognostic factors. Cancer 49:2414–2419PubMedGoogle Scholar
  32. 32.
    Eklund G, Malec E (1978): Sunlight and incidence of cutaneous malignant melanoma. Effect of latitude and domicile in Sweden. Scand J plast reconstr Surg 12:231–241PubMedGoogle Scholar
  33. 33.
    Eldh J, Boeryd B, Suurkuela M et al. (1985) Melanoma in Sweden: Experience at the University of Göteborg. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, 469–476Google Scholar
  34. 34.
    Elwood JM, Gallagher RP, Davison H, Hill GB (1985) Sunburn, suntan and the risk of cutaneous malignant melanoma. The Western Canada Melanoma Study. Brit J Cancer 51:543–549PubMedGoogle Scholar
  35. 35.
    Elwood JM, Gallagher RP, Hill GB et al. (1984) Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Brit med J 288:99–102Google Scholar
  36. 36.
    Elwood JM, Gallagher RP, Hill GB, Pearson JC (1985) Cutaneous melanoma in relation to intermittent and constant sun exposure. The Western Canada Melanoma Study. Intern J Cancer 35:427–433Google Scholar
  37. 37.
    Elwood JM, Lee JAH (1975) Recent data on the epidemiology of malignant melanoma. Sem Oncol 2:149–154Google Scholar
  38. 38.
    Elwood JM, Lee JAH (1979) Recent Data on the Epidemiology of Malignant Melanoma. In: Clark WH, Jr, Goldman LI, Mastrangelo MJ (eds) Human Malignant Melanoma. Grune & Stratton, New York — San Francisco — London, 261–272Google Scholar
  39. 39.
    Frichot BC, Lynch HT, Guirgis HA, Harris RE, Lynch JF (1977) New cutaneous pheno-type in familial malignant melanoma. Lancet 1:864–865PubMedGoogle Scholar
  40. 40.
    Fritz K, Ziegler H (1983) Beitrag der Saarländischen Krebsregisters zur Epidemiologie der Hauttumoren. Z Hautkrankh 58:901–915Google Scholar
  41. 41.
    Gallagher RP, Elwood JM, Hill GB et al. (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Brit J Cancer 52:901–907PubMedGoogle Scholar
  42. 42.
    Garbe C, Stadler R, Orfanos CE (1986) Prognose-orientierte Therapie bei malignem Melanom. Neuere Konzepte. Hautarzt 37:365–372PubMedGoogle Scholar
  43. 43.
    Gartmann H (1970) Trauma und malignes Melanom. Unfallheilkd 107:50–52Google Scholar
  44. 44.
    George PA, Fortner JG, Pack GT (1960) Melanoma with pregnancy. A report of 115 cases. Cancer 13:854–859PubMedGoogle Scholar
  45. 45.
    Green A, MacLennan R, Siskind V (1985): Common acquired naevi and the risk of malignant melanoma. Intern J Cancer 35:297–300Google Scholar
  46. 46.
    Green A, Siskind V, Bain C, Alexander J (1985): Sunburn and malignant melanoma. Brit J Cancer 51:393–397PubMedGoogle Scholar
  47. 47.
    Greene MH, Clark WH, Jr, Tucker MA et al. (1980) Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet IV:1024Google Scholar
  48. 48.
    Greene MH, Clark WH, Jr, Tucker MA et al. (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann intern Med 102:458–465PubMedGoogle Scholar
  49. 49.
    Greene MH, Young TJ, Clark WH, Jr (1981) Malignant melanoma in renal transplant recipients. Lancet 1:1196–1198PubMedGoogle Scholar
  50. 50.
    Grond K (1979) Zur Prognose des Melanomalignoms. Z Hautkrankh 54:559–570Google Scholar
  51. 51.
    Hacene K, Le Doussal V, Brunet M et al. (1983) Prognostic index for clinical stage I cutaneous malignant melanoma. Cancer Res 43:2991–2996PubMedGoogle Scholar
  52. 52.
    Hauss H, Proppe A (1972) Melanomalignom. Klinische Dokumentation: Lokalisation und Geschlecht. Arch Dermat Forsch 244:193–195Google Scholar
  53. 53.
    Heenan PJ (1985) Cutaneous malignant melanoma in Western Australia. Pathology 17:321–327PubMedGoogle Scholar
  54. 54.
    Heenan PJ, Holman CD (1983) Survival from invasive cutaneous malignant melanoma in Western Australia and the Oxford Region: A comparative histological study of high and low incidence populations. Pathology 15:147–152PubMedGoogle Scholar
  55. 55.
    Heite H-J (1981) Epidemiologie und Prognose. In: Weidner F, Tonak J (Hrsg) Das Maligne Melanom der Haut. Perimed, Erlangen, 11–26Google Scholar
  56. 56.
    Helmrich SP, Rosenberg L, Kaufman DW et al. (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J nat Cancer Inst 72:617–620PubMedGoogle Scholar
  57. 57.
    Hermanek P, Hornstein OP, Tonak J, Weidner F (1976) Malignes Melanom. In-vasionstiefe und Melanomtyp. Beitr Path 157:269–282Google Scholar
  58. 58.
    Hersey P, Stone DE, Morgan G, McCarthy WH (1977) Previous pregnancy as a protective factor against death from melanoma. Lancet 1:451–452PubMedGoogle Scholar
  59. 59.
    Hinds MW (1979) Anatomic distribution of malignant melanoma of the skin among noncaucasians in Hawaii. Brit J Cancer 40:497–499PubMedGoogle Scholar
  60. 60.
    Holman CD, Armstrong BK (1984) Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma. J nat Cancer Inst 72:257–266PubMedGoogle Scholar
  61. 61.
    Holman CD, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: Exogeneous sex hormones and reproductive factors. Brit J Cancer 50:673–680PubMedGoogle Scholar
  62. 62.
    Houghton AN, Flannery J, Viola MV (1981) Malignant melanoma of the skin occuring during pregnancy. Cancer 48:407–410PubMedGoogle Scholar
  63. 63.
    Houghton A, Munster EW, Viola MV (1978) Increased incidence of malignant melanoma after peaks of sunspot activity. Lancet 11:759–760Google Scholar
  64. 64.
    Howe GM (ed) (1986) Global Geocancerology: A World Geography of Human Cancers. Churchill Livingstone: Edinburgh-London-Melbourne-New YorkGoogle Scholar
  65. 65.
    Howe GM (1986) International Variations in Cancer Incidence and Mortality. In: Howe GM (ed) Global Geocancerology. Churchill Livingstone, Edinburgh-London-Melbourne-New York, 3–42Google Scholar
  66. 66.
    Illig L, Paul E, Hundeiker M et al. (1983) „Public and Professional Melanoma Education“. Ein deutsches Modell zur Verbesserung der Melanom-Früherkennung bzw. -Erfassung mit publizistischen Methoden auf dem Boden korrigierter Vorstellungen über Melanom und Naevus. Z Hautkrkh 58:73–112Google Scholar
  67. 67.
    Jensen OM, Bolander AM (1980) Trends in malignant melanoma of the skin. World Hlth Statist Quart 33:2–25Google Scholar
  68. 68.
    Jung HD (1982) Epidemiologie des malignen Melanoms in der Deutschen Demokratischen Republik und in der Bundesrepublik Deutschland. Hautarzt 33:636–699PubMedGoogle Scholar
  69. 69.
    Jung HD (1985) Aktuelle Probleme der Epidemiologie am Beispiel des malignen Melanoms der Haut. Akt Dermat 11:154–156Google Scholar
  70. 70.
    Karakousis CP, Lopez RE, Bhakoo HS et al. (1980) Estrogen and progesteron receptors and Tamoxifen in malignant melanoma. Cancer Treatm Rep 64:819–827Google Scholar
  71. 71.
    Kelly JW, Blois MS, Sagebiel RW (1985) Frequency and duration of patient follow-up after treatment of a primary malignant melanoma. J Am er Acad Dermat 13:756–760Google Scholar
  72. 72.
    Klepp O, Magnus K (1979) Some environmental and bodily characteristics of melanoma patients. A case-control study. Intern J Cancer 23:482–486Google Scholar
  73. 73.
    Kopf AW, Rigel DS, Friedman RJ (1982) The rising incidence and mortality rate of malignant melanoma. J Dermat Surg Oncol 8:760–761Google Scholar
  74. 74.
    Kuehnl-Petzold Ch, Wiebelt H, Berger H, Wagner G (1983) A proposal for staging malignant melanoma. Arch Dermat Res 275:255–256Google Scholar
  75. 75.
    Landthaler M, Braun-Falco O (1979) Familiäres hereditäres malignes Melanom. Med Klin 74:353–357PubMedGoogle Scholar
  76. 76.
    Larsen TE, Grude TH (1978) A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 1. Histological classification, sex and age of the patients, localization of tumour and prognosis. Acta path microbiol immun scand Sect A 86:437–450Google Scholar
  77. 77.
    Lea AJ (1965) Malignant melanoma of the skin. The relationship to trauma. Ann roy Coll Surg 37:169–176Google Scholar
  78. 78.
    Lee JAH (1982) Melanoma. In: Schottenfeld D, Fraumeni JF Jr, (eds) Cancer Epidemiology and Prevention. Saunders, Philadelphia, pp 984–995Google Scholar
  79. 79.
    Lee JAH (1985) The Causation of Melanoma. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 303–311Google Scholar
  80. 80.
    Lee JAH, Hill GB (1970) Marriage and fatal malignant melanoma in females. Amer J Epidem 91:48–51Google Scholar
  81. 81.
    Lee JAH, Petersen GR, Stevens RG, Vesanen K (1979) The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States. Amer J Epidem 110:734–739Google Scholar
  82. 82.
    Lee JAH, Strickland D (1980) Malignant melanoma. — Social status and outdoor work. Brit J Cancer 41:757–763PubMedGoogle Scholar
  83. 83.
    Lee JAH, Yongchaiyudha S (1971) Incidence of and mortality from malignant melanoma by anatomical site. J nat Cancer Inst 47:253–263PubMedGoogle Scholar
  84. 84.
    Lerner AB, Kirkwood JM (1984) Vitiligo and melanoma: Can genetically abnormal melanocytes result in both vitiligo and melanoma within a single family? J Amer Acad Dermat 11:696–701Google Scholar
  85. 85.
    Lerner AB, Nordlund JJ, Kirkwood JM (1979) Effects of oral contraceptives and pregnancy on melanomas. New Engl J Med 301:47PubMedGoogle Scholar
  86. 86.
    Lewis MG (1967) Malignant melanoma in Uganda. Brit J Cancer 21:483–495PubMedGoogle Scholar
  87. 87.
    Liestøl K, Larsen TE, Grude TH (1982) A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 8. The relative prognostic value of various clinical and histological features evaluated by Cox’s regression model. Acta path microbiol immun scand Sect A 90:449–454Google Scholar
  88. 88.
    Lynch HT, Fusaro RM, Danes BS et al. (1983) A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet 8:325–358PubMedGoogle Scholar
  89. 89.
    MacDonald EJ (1948) Malignant Melanoma in Connecticut. In: Miner RW, Gordon M (eds) The Biology of Melanomas. N.Y. Acad Sci, Special Publ. No 4, New York, pp 71–81Google Scholar
  90. 90.
    MacKie RM, Aitchison T (1982) Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Brit J Cancer 46:955–960PubMedGoogle Scholar
  91. 91.
    MacKie RM, Smyth JF, Soutar DS et al. (1985) Malignant melanoma in Scotland 1979–1983. Lancet II:859–863Google Scholar
  92. 92.
    Magnus K (1973) Incidence of malignant melanoma of the skin in Norway, 1955–1970. Cancer 32:1275–1286PubMedGoogle Scholar
  93. 93.
    Magnus K (1977) Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis. Cancer 40:389–397PubMedGoogle Scholar
  94. 94.
    Magnus K (1977) Incidence of malignant melanoma of the skin in the five nordic countries. Significance of solar radiation. Intern J Cancer 20:477–485Google Scholar
  95. 95.
    Maize JC (1977) Skin cancer in immunosuppressed patients. J Amer med Ass 237:1857–1858Google Scholar
  96. 96.
    Mastrangelo MJ, Bellet RE, Berd D (1979) Prognostic Factors. In: Clark WH, Jr, Goldman LI, Mastrangelo MJ (eds) Human Malignant Melanoma. Grune and Stratton, New York-San Francisco-London, pp 273–282Google Scholar
  97. 97.
    McCarthy WH, Black AL, Milton GW (1980) Melanoma in New South Wales. An epidemiologic survey 1970–1976. Cancer 46:427–432PubMedGoogle Scholar
  98. 98.
    McGovern VJ (1952) Melanoblastoma. Med J Austr 1:139–142Google Scholar
  99. 99.
    McLeod GR, Davis NC, Little JH et al. (1985) Melanoma in Queensland, Australia: Experience of the Queensland Melanoma Project. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 379–387Google Scholar
  100. 100.
    Milton GW, Balch ChM, Shaw HM (1985) Clinical Characteristics. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 13–28Google Scholar
  101. 101.
    Muir CS, Choi NW, Schifflers E (1981) Time Trends in Cancer Mortality in some Countries. Their Possible Causes and Significance. In: Skandia International Symposia. Medical Aspects of Mortality Statistics. Almquist & Wiksell Internat., Stockholm, pp 269–309Google Scholar
  102. 102.
    Niebauer G, Becerano S, Kokoschka EM (1984) Zur Zunahme der Hautmelanome in Österreich (1926–1980): Wien klin Wschr 96:423–425PubMedGoogle Scholar
  103. 103.
    Pack GT, Scharnagel IM (1951) Prognosis for malignant melanoma in pregnant women. Cancer 4:324–334PubMedGoogle Scholar
  104. 104.
    Pathak DR, Samet JM, Howard CA, Key CR (1982) Malignant melanoma of the skin in New Mexico 1969–1977. Cancer 50:1440–1446PubMedGoogle Scholar
  105. 105.
    Plesko I, Somogyi J, Dimitrova E et al. (1985) Epidemiologic aspects of malignant melanoma in Slovakia. Neoplasma 32:273–284PubMedGoogle Scholar
  106. 106.
    Polednak AP (1985) Malignant melanoma of the skin in upstate New York: recent trends and characteristics. Cancer Detect Prevent 8:485–495PubMedGoogle Scholar
  107. 107.
    Ratu M (1986) The USSR. In: Hows GM (ed) Global Geocancerology, Churchill Livingstone, Edinburgh-London-Melbourne-New York, pp 223–237Google Scholar
  108. 108.
    Reimer RR, Clark WH, Jr, Greene MH et al. (1978) Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. J Amer med Ass 239:744–746Google Scholar
  109. 109.
    Reintgen DS, McCarty KM, Cox E, Seigier HF: Malignant melanoma in black American and white American populations: A comparative review. J Amer med Ass 248:1856–1859Google Scholar
  110. 110.
    Reintgen DS, McCarty KS, Vollmer R et al. (1985) Malignant melanoma and pregnancy. Cancer 55:1340–1344PubMedGoogle Scholar
  111. 111.
    Reynolds P, Austin D, Thomas J (1982) Familial and occupational risks associated with malignant melanoma of the skin. Amer J Epidem 116:570Google Scholar
  112. 112.
    Sadoff C, Winkley J, Tyson S (1973) Is malignant melanoma an endocrine-dependent tumor? Oncology 27:244–257PubMedGoogle Scholar
  113. 113.
    Schauer A (1970) Über die Bedeutung des Traumas bei der Geschwulstentstehung, insbesondere des malignen Melanoms, vom Standort des Pathologen. Unfallheilkd 107:9–18Google Scholar
  114. 114.
    Scher KS, Scher NS, O’Connor DS (1981) Malignant melanoma in West Virginia. South med J 74:6–8PubMedGoogle Scholar
  115. 115.
    Schmoeckel Ch, Bockeibring A, Bockeibring H, Koutsis J, Braun-Falco O (1983) Low-and high risk malignant melanoma. I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer 19:227–235Google Scholar
  116. 116.
    Schmoeckel Ch, Bockelbring A, Bockelbring H, Braun-Falco O (1983) Low- and high risk malignant melanoma. II. Multivariate analyses for a prognostic classification. Eur J Cancer 19:237–243Google Scholar
  117. 117.
    Schreiber MM, Moon TE, Bozzo PD (1984) Chronic solar ultraviolet damage associated with malignant melanoma of the skin. J Amer Acad Dermat 10:755–759Google Scholar
  118. 118.
    Scotto J, Fears TR, Fraumeni JF, Jr. (1982) Solar Radiation. In: Schottenfeld D, Fraumeni JF, Jr (eds) Cancer Epidemiology and Prevention. Saunders, Philadelphia, pp 254–276Google Scholar
  119. 119.
    Seebach v HB, Tille MM, Bahmer F (1985) Das maligne Melanom der Haut im Krebsregister des Saarlandes 1968–1981. Pathologe 6:231–241Google Scholar
  120. 120.
    Shaw HM, McGovern VJ, Milton GW et al. (1980) Malignant Melanoma. Influence of site of lesion and age of patient in the female superiority of survival. Cancer 46:2731–2735PubMedGoogle Scholar
  121. 121.
    Shaw HM, Milton GW, Farago G, McCarthy WH (1978) Endocrine influences on survival from malignant melanoma. Cancer 42:669–677PubMedGoogle Scholar
  122. 122.
    Shiu MH, Schottenfeld D, Maclean B (1976) Adverse effect of pregnancy on melanoma. Cancer 37:181–187PubMedGoogle Scholar
  123. 123.
    Smith T (1979) The Queensland Melanoma Project. An exercise in health education. Brit med J 1:253–254PubMedGoogle Scholar
  124. 124.
    Soong S-J (1985) A Computerized Mathematical Model and Scoring System for Predicting Outcome in Melanoma Patients. In: Balch, ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 353–367Google Scholar
  125. 125.
    Storck H (1977) Klinik, Statistik und Risikofaktoren des malignen Melanoms. Dermatologica 155:129–142PubMedGoogle Scholar
  126. 126.
    Takematsu H, Tomita Y, Kato T et al. (1985) Melanoma in Japan: Experience at Tohoku University Hospital, Sendai. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 499–506Google Scholar
  127. 127.
    Teppo L, Pakkanen M, Hakulinen T (1978) Sunlight as a risk factor of malignant melanoma of the skin. Cancer 41:2018–2027PubMedGoogle Scholar
  128. 128.
    Tonak J, Hermanek P (1983) Die unterschiedliche Prognose von Rumpf- und Extremitäten-Melanomen. Lebensvers med 35:61–63Google Scholar
  129. 129.
    Tonak J, Hermanek P, Weidner F et al. (1985) Melanoma in Germany: Experience at the University of Erlangen-Nuernberg. In: Balch ChM, Milton GW (eds) Cutaneous Melanoma. Lippincott, Philadelphia, pp 483–494Google Scholar
  130. 130.
    Triltsch H (1981) Die Systematik des malignen Melanoms der Haut als Grundlage des Behandlungsplanes. Dtsch Ärztebl 78:609–612Google Scholar
  131. 131.
    Veronesi U, Cascinelli N, Bufalino R (1976) Evaluation of the risk of multiple primaries in malignant cutaneous melanoma. Tumori 62:127–130PubMedGoogle Scholar
  132. 132.
    Wagner G, Becker N (1982) Die Krebssterblichkeit in Mitteleuropa. Derzeitige Situation und zeitlicher Trend. Dtsch Ärztebl 79:37–44Google Scholar
  133. 133.
    Wallace DC, Exton LA, McLeod GRC (1971) Genetic factor in malignant melanoma. Cancer 27:1262–1266PubMedGoogle Scholar
  134. 134.
    Waterhouse J, Muir CS, Shanmugaratnam K, Powell J (eds) (1982) Cancer Incidence in Five Continents Vol IV. IARC Scient Publ No 42, Internat. Agency for Research on Cancer, LyonGoogle Scholar
  135. 135.
    Weiss NS, Flannery JT (1978) The relationship of marital status to survival from melanoma. Cancer 42:296–298PubMedGoogle Scholar
  136. 136.
    White LP, Linden G, Breslow L, Harzfeld L (1961) Studies on melanoma: The effect of pregnancy on survival in human melanoma. J Amer med Ass 177:235–238Google Scholar
  137. 137.
    Wiskemann A (1974) Zur Melanomentstehung durch chronische Lichteinwirkung. Hautarzt 25:20–22PubMedGoogle Scholar
  138. 138.
    Young JL, Jr, Pollack ES (1982) The Incidence of cancer in the United States. In: Schottenfeld D, Fraumeni JF, Jr (eds) Cancer Epidemiology and Prevention. Saunders WB Co, Philadelphia, pp 138–165Google Scholar
  139. 139.
    Younis FM, Fernando ON, Sweny P et al. (1980) Malignant melanoma in patients with renal transplants. Lancet II:1141Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Gustav Wagner

There are no affiliations available

Personalised recommendations